In Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs

Journal of Bone and Mineral Research

Volumn 30, Issue 8, 2015, Pages 1441-1444

  Allen, Matthew R ^a   Territo, Paul R ^a   Lin, Chen ^a   Persohn, Scott ^a   Jiang, Lei ^a   Riley, Amanda A ^a   McCarthy, Brian P ^a   Newman, Christopher L ^a   Burr, David B ^a   Hutchins, Gary D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CORTICAL BONE; HYDRATION; NONINVASIVE IMAGING; SERMS

Indexed keywords

RALOXIFENE; SODIUM CHLORIDE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEAGLE; BONE MATRIX; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HYDRATION; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL NOISE RATIO; TIBIA; ULTRA SHORT ECHOTIME MAGNETIC RESONANCE IMAGING; ANIMAL; DOG; METABOLISM; RADIOGRAPHY;

ANIMALS; DOGS; FEMALE; MAGNETIC RESONANCE IMAGING; RALOXIFENE HYDROCHLORIDE; TIBIA; WATER;

EID: 84937161490     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2470     Document Type: Article

References (19)

1. Ettinger B, Black DM, Mitlak BH, et al., Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999; 282 (7): 637-45.
2. Riggs B, Melton L III,. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res. 2002; 17 (1): 11-4.
3. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD,. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res. 2002; 17 (1): 1-10.
4. Allen MR, Iwata K, Sato M, Burr DB,. Raloxifene enhances vertebral mechanical properties independent of bone density. Bone. 2006; 39 (5): 1130-5.
5. Allen M, Hogan H, Hobbs W, Koivuniemi A, Koivuniemi M, Burr D,. Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone. Endocrinology. 2007; 148 (8): 3908-13.
6. Gallant MA, Brown DM, Hammond M, et al., Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties. Bone. 2014; 61 (C): 191-200.
7. Diaz E, Chung CB, Bae WC, et al., Ultrashort echo time spectroscopic imaging (UTESI): an efficient method for quantifying bound and free water. NMR Biomed. 2011; 25 (1): 161-8.
8. Biswas R, Bae W, Diaz E, et al., Ultrashort echo time (UTE) imaging with bi-component analysis: bound and free water evaluation of bovine cortical bone subject to sequential drying. Bone. 2012; 50 (3): 749-55.
9. Du J, Hermida JC, Diaz E, Corbeil J,. Assessment of cortical bone with clinical and ultrashort echo time sequences. Magn Reson Med. 2013; 70: 697-704.
10. Techawiboonwong A, Song HK, Leonard MB, Wehrli FW,. Cortical bone water: in vivo quantification with ultrashort echo-time MR imaging. Radiology. 2008; 248 (3): 824-33.
11. Aref M, Gallant MA, Organ JM, et al., In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs. Bone. 2013; 56 (2): 449-53.
12. Allen M, Iwata K, Phipps R, Burr D., Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone. 2006; 39 (4): 872-9.
13. Li S, Chang EY, Bae WC, et al., The effect of excitation and preparation pulses on nonslice selective 2D UTE bicomponent analysis of bound and free water in cortical bone at 3T. Med Phys. 2014 Feb; 41 (2): 022306.
14. Miller AJ, Joseph PM,. The use of power images to perform quantitative analysis on low SNR MR images. Magn Reson Imaging. 1993; 11 (7): 1051-6.
15. Bryant HU, Glasebrook AL, Yang NN,. A pharmacological review of raloxifene. J Bone Miner Metab. 1996; 14: 1-9.
16. Allen M, Kubek D, Burr D., Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs. J Bone Miner Res. 2010; 25 (1): 98-105.
17. Allen MR, Kubek DJ, Burr DB, Ruggiero SL, Chu T-MG,. Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs. Osteoporos Int. 2011; 22 (2): 693-702.
18. Boyce RW, Paddock CL, Gleason JR, Sletsema WK, Eriksen EF,. The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res. 2009; 10 (2): 211-21.
19. Bae WC, Chen PC, Chung CB, Masuda K, D'Lima D, Du J,. Quantitative ultrashort echo time (UTE) MRI of human cortical bone: correlation with porosity and biomechanical properties. J Bone Miner Res. 2012; 27 (4): 848-57.